Background
coronavirus disease, bacterial infection
SECONDARY, BACTERIAL INFECTION

According to the American College of Gastroenterology (ACG) Clinical Guideline, The main etiologies for the failure of anti Azithromycin was suggested to be a beneficial drug against coronavirus disease of 2019 (COVID-19), due to its antiviral, anti-inflammatory properties and to prevent secondary bacterial infection [Although clinical trials have explored that drugs like azithromycin, chloroquine, and ivermectin are ineffective against COVID-19, they are frequently prescribed by doctors and self-administered by the people in many world regions during the COVID-19 pandemic [The primary objective of this study was to address the efficacy of clarithromycin- and levofloxacin-based regimens as the first-line eradication therapy of 